Acuta Capital Partners’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-100,000
| Closed | -$944K | – | 66 |
|
|
2017
Q1 | $944K | Buy |
+100,000
| New | +$944K | 0.22% | 35 |
|
|
2016
Q4 | – | Sell |
-432,370
| Closed | -$2.74M | – | 60 |
|
|
2016
Q3 | $2.74M | Sell |
432,370
-16,515
| -4% | -$105K | 1.03% | 27 |
|
|
2016
Q2 | $1.89M | Buy |
448,885
+216,085
| +93% | +$912K | 0.91% | 31 |
|
|
2016
Q1 | $1.02M | Buy |
+232,800
| New | +$1.02M | 0.57% | 30 |
|